Pfizer Inc. recalls Relpax (eletriptan HBr) 40 mg, a) 12 tablets 2 cards x six 40 mg tablets per blister pack, NDC 0049-2340-05; b) 6
Pfizer recalls Relpax 40mg tablets due to a labeling error showing 20mg instead of 40mg per tablet. This may cause incorrect dosing. Affected products have specific NDC numbers and expiration dates.
Lower-risk recall
Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.
Contact the company & request your remedy
What happened, in plain English
Pfizer is recalling Relpax 40mg tablets because the label shows each tablet contains 20mg eletriptan instead of 40mg. This could lead to underdosing if taken as directed. The recall affects specific packaging and lot numbers. Read more at govinfonow.com/recall/38871-pfizer-relpax-40mg-tablets-recall-label-error-on-strength.
Source Summary by GovInfoNow · govinfonow.com/recall/38871-pfizer-relpax-40mg-tablets-recall-label-error-on-strength · Updated October 5, 2026 · FDA enforcement record: FDA #D-1278-2019
Cite this page
“Pfizer Relpax 40mg Tablets Recall: Label Error on Strength.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38871-pfizer-relpax-40mg-tablets-recall-label-error-on-strength. Based on FDA recall #D-1278-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1278-2019%22&limit=1).
Why it’s dangerous
The label error on the secondary packaging shows each tablet contains 20mg eletriptan hydrobromide instead of 40mg. This could result in underdosing if the patient takes the tablet as intended, potentially making the treatment less effective for migraines.
Who’s affected
People who have the recalled Relpax 40mg tablets with the specific NDC numbers and lot numbers listed. Those taking the medication for migraines are most at risk if they rely on the incorrect dosage.
How to tell if you have this one
Check for Relpax 40mg tablets with NDC 0049-2340-05 or 0049-2340-45. The packaging includes specific lot numbers and expiration dates listed in the recall notice.
- Brand
Pfizer- Category
Drug
What to do — step by step
Check Product Label
Look for the label error showing 20mg instead of 40mg per tablet on the secondary packaging.
Questions people ask
Is this recall dangerous?
No, this is a labeling error that could lead to underdosing, but it does not pose an immediate risk of injury or serious harm.
What should I do if I have the recalled product?
The recall does not provide a specific remedy, so you should check the product label for the error and contact your doctor or pharmacist for guidance.
Which products are affected?
Relpax 40mg tablets with NDC 0049-2340-05 or 0049-2340-45, including specific lot numbers and expiration dates listed in the recall.
Contact Pfizer
We’ve drafted a message you can send Pfizer to request your refund or repair — edit it as you like.
Subject: Recall D-1278-2019 — Pfizer Pfizer Hello, I own a Pfizer that is covered by recall D-1278-2019 from Pfizer. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1278-2019 (April 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1278-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.